Eli Lilly and Company
RAMUCIRUMAB FOR THE TREATMENT OF CANCERS IN PEDIATRIC PATIENTS
Last updated:
Abstract:
The invention provides for methods, treatments, and uses for ramucirumab for the treatment of pediatric cancers.
Status:
Application
Type:
Utility
Filling date:
29 Mar 2019
Issue date:
3 Jun 2021